StockData
FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31

Freenome, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 15, 2026
$12.57+0.82 (+6.98%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

SEC filings

20 of Freenome's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report8-KOct 20, 2026Oct 20, 2026SEC EDGAR
Current report8-KJul 27, 2026Jul 27, 2026SEC EDGAR
Current report8-KJul 20, 2026Jul 24, 2026SEC EDGAR
Current report8-KJul 15, 2026Jul 15, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Jul 15, 2026SEC EDGAR
Current report8-KJul 9, 2026Jul 9, 2026SEC EDGAR
Current report8-KJun 18, 2026Jun 18, 2026SEC EDGAR
Current report8-KJun 10, 2026Jun 10, 2026SEC EDGAR
Proxy statementDEF 14AJun 10, 2026May 14, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 13, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 12, 2026SEC EDGAR
Current report8-KDec 5, 2025Dec 5, 2025SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 13, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Aug 13, 2025SEC EDGAR
Quarterly report10-QMar 31, 2025May 12, 2025SEC EDGAR
Annual report10-KDec 31, 2024Mar 19, 2025SEC EDGAR
Quarterly report10-QSep 30, 2024Nov 13, 2024SEC EDGAR
Quarterly report10-QJun 30, 2024Aug 14, 2024SEC EDGAR
Current report8-KJun 13, 2024Jun 20, 2024SEC EDGAR
Current report8-KJun 11, 2024Jun 13, 2024SEC EDGAR